Log in to save to my catalogue

Cytoreductive surgery is feasible in patients with limited regional platinum-resistant recurrent ova...

Cytoreductive surgery is feasible in patients with limited regional platinum-resistant recurrent ova...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_afe9c756ed0242c8a72b31706195cbc6

Cytoreductive surgery is feasible in patients with limited regional platinum-resistant recurrent ovarian cancer

About this item

Full title

Cytoreductive surgery is feasible in patients with limited regional platinum-resistant recurrent ovarian cancer

Publisher

London: BioMed Central Ltd

Journal title

World journal of surgical oncology, 2023-11, Vol.21 (1), p.1-375, Article 375

Language

English

Formats

Publication information

Publisher

London: BioMed Central Ltd

More information

Scope and Contents

Contents

Introduction To evaluate the efficacy of cytoreductive surgery versus chemotherapy for the treatment of limited regional, platinum-resistant ovarian cancer (PROC). Materials and methods The clinical records of all patients with PROC treated in our center between March 2015 and March 2022 were retrospectively reviewed. We compared the oncology outco...

Alternative Titles

Full title

Cytoreductive surgery is feasible in patients with limited regional platinum-resistant recurrent ovarian cancer

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_afe9c756ed0242c8a72b31706195cbc6

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_afe9c756ed0242c8a72b31706195cbc6

Other Identifiers

ISSN

1477-7819

E-ISSN

1477-7819

DOI

10.1186/s12957-023-03230-3

How to access this item